Vietnam MOH registration 2402547ĐKLH/BYT-HTTB

CK-MB Quantitative Testing Control Reagent Kit

VN: Bộ thuốc thử, chất hiệu chuẩn xét nghiệm định lượng CK-MB
Vietnam flagVietnam·Risk Class TTBYT Loại C·IMMULITE/ IMMULITE 1000 CK-MB (Name on Label: IMMULITE/IMMULITE Systems 1000 CK-MB)·Siemens Healthcare Diagnostics Products Limited·Registered Aug 30, 2024
Registration details
Analysis ID
2402547ĐKLH/BYT-HTTB
Submission ID
000.00.04.G18-210719-0012
Product Type
IMMULITE/ IMMULITE 1000 CK-MB (Name on Label: IMMULITE/IMMULITE Systems 1000 CK-MB)
Product Code
10381016/ LKMB1
Company information
Manufacturer Country
UNITED KINGDOM
Product Owner
Siemens Healthineers
Authorized Representative
CÔNG TY TNHH SIEMENS HEALTHCARE
Technical details
Intended Use
To be used in in vitro diagnostic with the IMMULITE and IMMULITE 1000 Analyzers - to measure the quantitative isoenzyme MB of creatine kinase (CK-MB) in heparin-anticoagulated blood or serum, as a supportive measure in the management of patients and in the risk assessment of myocardial infarction.
Dates and status
Registration Date
Aug 30, 2024
About this record

Access comprehensive regulatory information for CK-MB Quantitative Testing Control Reagent Kit in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402547ĐKLH/BYT-HTTB and manufactured by Siemens Healthcare Diagnostics Products Limited. The authorized representative in Vietnam is CÔNG TY TNHH SIEMENS HEALTHCARE.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices